Abstract:Purpose: Models of integrated, multidisciplinary care are optimal in the setting of complex, chronic diseases and in the overlap of medical and mental health disease, both of which apply to alcohol-related liver disease (ALD). Alcohol use disorder (AUD) drives nearly all cases of ALD, and coexisting mental health disease is common. ALD is a complex condition with severe clinical manifestations and high mortality that can occasionally lead to liver transplantation. As a result, integrated care for ALD is an attractive proposition. The aim of this narrative review was to: (1) review the overlapping and concerning trends in the epidemiology of AUD and ALD; (2) use a theoretical framework for integrated care known as the "five-component model" as a basis to highlight the need for integrated care and the overlapping clinical manifestations and management of the 2 conditions; and (3) review the existing applications of integrated care in this area. Methods: We performed a narrative review of epidemiology, clinical manifestations, and management strategies in AUD and ALD, with a particular focus on areas of overlap that are pertinent to clinicians who manage each disease. Previously published models were reviewed for integrating care in AUD and ALD, both in the general ALD population and in the setting of liver transplantation. Findings: The incidences of AUD and ALD are rising, with a pronounced acceleration driven by the Coronavirus Disease 2019 pandemic. Hepatologists are underprepared to diagnose and treat AUD despite its high prevalence in patients with liver disease. A patient who presents with overlapping clinical manifestations of both AUD and ALD may not fit neatly into typical treatment paradigms for each individual disease but rather will require new management strategies that are appropriately adapted. As a result, the dimensions of integrated care, including collective ownership of shared goals, interdependence among providers, flexibility of roles, and newly created professional activities, are highly pertinent to the holistic management of both diseases. Implications: Integrated care models have proliferated as recognition grows of the dual pathology of AUD and ALD. Ongoing coordination across disciplines and research in the fields of hepatology and addiction medicine are needed to further elucidate optimal mechanisms for collaboration and improved quality of care.

Research Priorities and Future Landscape of Clinical Trials in Alcohol-Associated Liver Disease

Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement

Barriers to Alcohol Use Disorder Treatment in Patients with Alcohol-Associated Liver Disease

Shaping new paths in clinical trial design to address alcohol use disorders and alcohol-associated liver disease

Management of Alcohol-Associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities

Integrated Multidisciplinary Care Model to Manage the Dual Pathology of Alcohol Use Disorder and of Liver Disease

Pharmacotherapy of alcoholic liver disease in clinical practice

Alcohol-associated liver disease - a current overview

Treatment of Alcohol Use Disorder: Behavioral and Pharmacologic Therapies

Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder

Alcohol use disorder in community management of chronic liver diseases

Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting

Multidisciplinary Care of Alcohol-related Liver Disease and Alcohol Use Disorder: A Narrative Review for Hepatology and Addiction Clinicians

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

Changing landscape of alcohol‐associated liver disease in younger individuals, women, and ethnic minorities

Nutritional and microbiota-based therapeutic intervention for alcohol-associated liver disease: Pathogenesis to therapeutic insights

The pharmacological management of alcohol-related cirrhosis: what's new?

Challenge and direction of research on alcoholic liver disease

New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease

ACG Clinical Guideline: Alcohol-Associated Liver Disease

Noninvasive Tests in Assessment of Patients with Alcohol-Associated Liver Disease